Cencora (COR)
Health Care · Pharmaceutical and Healthcare Product Distribution
North America's largest pharmaceutical and healthcare product distributor, serving pharmacies, hospitals, and health systems with branded and generic drugs, medical supplies, and specialty healthcare services.
What Cencora does
Cencora is a healthcare distributor that sources, warehouses, and distributes pharmaceutical products, medical supplies, and healthcare services to pharmacies, hospitals, clinics, and healthcare systems across North America. The company operates a large-scale logistics and distribution network supplying both branded and generic medications, as well as specialty pharmaceuticals and healthcare solutions. Cencora also provides consulting services, data analytics, and specialty healthcare services through acquisitions in oncology and ophthalmology care.
Themes: ["Pharmaceutical supply chain"]
Fundamentals
- Price$302.46 as of 2026-07-09 close
- Market cap$58.8B as of 2026-07-10
- 1-year return+0.8% as of 2026-07-09 close
- P/E23.09 as of 2026-07-10
- Net margin+0.8% as of 2026-07-10
- Gross margin+3.8% as of 2026-07-10
- ROE+115.9% as of 2026-07-10
- Debt / equity3.65 as of 2026-07-10
- Revenue growth (YoY)+6.0% as of 2026-07-10
- Revenue CAGR (3y)+10.4% SEC XBRL
- Beta0.58 as of 2026-07-10
Dividend: yield +0.8%; 4-year non-decreasing per-share dividend streak (SEC XBRL).
Key risks (from latest filing)
["Exposure to generic pharmaceutical price deflation and unfavorable brand-to-generic pricing trends, impacting margins on core distribution business"]
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.